FR2969926B1 - Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza - Google Patents

Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza

Info

Publication number
FR2969926B1
FR2969926B1 FR1150049A FR1150049A FR2969926B1 FR 2969926 B1 FR2969926 B1 FR 2969926B1 FR 1150049 A FR1150049 A FR 1150049A FR 1150049 A FR1150049 A FR 1150049A FR 2969926 B1 FR2969926 B1 FR 2969926B1
Authority
FR
France
Prior art keywords
heteroglycanes
arabinogalactanes
apiogalacturonanes
sulfates
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1150049A
Other languages
English (en)
Other versions
FR2969926A1 (fr
Inventor
Bruno Lina
Olivier Ferraris
Ho Hong Hai Vo
Francois-Loic Cosset
Judit Szecsi
Alain Heyraud
Hugues Lortat-Jacob
Julia Bartoli
Rabia Sadir
Thierry Livache
Benoit Darblade
Stephane Havet
Silvere Bonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Elicityl
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Commissariat a lEnergie Atomique CEA
Institut National de la Sante et de la Recherche Medicale INSERM
Elicityl
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Commissariat a lEnergie Atomique CEA, Institut National de la Sante et de la Recherche Medicale INSERM, Elicityl, Commissariat a lEnergie Atomique et aux Energies Alternatives CEA filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1150049A priority Critical patent/FR2969926B1/fr
Priority to CN201280011695.2A priority patent/CN103476418B/zh
Priority to BR112013017178A priority patent/BR112013017178A2/pt
Priority to PCT/FR2012/050017 priority patent/WO2012093234A2/fr
Priority to US13/977,780 priority patent/US9011939B2/en
Priority to EP12702582.3A priority patent/EP2675462A2/fr
Publication of FR2969926A1 publication Critical patent/FR2969926A1/fr
Application granted granted Critical
Publication of FR2969926B1 publication Critical patent/FR2969926B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
FR1150049A 2011-01-04 2011-01-04 Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza Active FR2969926B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1150049A FR2969926B1 (fr) 2011-01-04 2011-01-04 Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
CN201280011695.2A CN103476418B (zh) 2011-01-04 2012-01-03 用于治疗由流感病毒引起的疾病的硫酸阿拉伯半乳聚糖、芹菜糖半乳糖醛酸聚糖和硫酸杂聚糖
BR112013017178A BR112013017178A2 (pt) 2011-01-04 2012-01-03 arabinogalactanas sulfatadas, apiogalacturonanas e heteroglicanas sulfatadas para o tratamento de doenças causadas pelo vírus influenza
PCT/FR2012/050017 WO2012093234A2 (fr) 2011-01-04 2012-01-03 Arabinogalactanes sulfates, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
US13/977,780 US9011939B2 (en) 2011-01-04 2012-01-03 Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus
EP12702582.3A EP2675462A2 (fr) 2011-01-04 2012-01-03 Arabinogalactanes sulfates, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1150049A FR2969926B1 (fr) 2011-01-04 2011-01-04 Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza

Publications (2)

Publication Number Publication Date
FR2969926A1 FR2969926A1 (fr) 2012-07-06
FR2969926B1 true FR2969926B1 (fr) 2017-03-10

Family

ID=44170105

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1150049A Active FR2969926B1 (fr) 2011-01-04 2011-01-04 Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza

Country Status (6)

Country Link
US (1) US9011939B2 (fr)
EP (1) EP2675462A2 (fr)
CN (1) CN103476418B (fr)
BR (1) BR112013017178A2 (fr)
FR (1) FR2969926B1 (fr)
WO (1) WO2012093234A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104068277B (zh) * 2014-07-04 2016-03-30 芜湖欧标农业发展有限公司 翅柄铁线蕨作为制备抗禽流感的鸡饲料添加剂中的应用
AU2016276972B8 (en) 2015-06-10 2022-09-22 Lemnature Aquafarms Corporation Methods and systems for extracting protein and carbohydrate rich products from a microcrop and compositions thereof
BR112017026539B1 (pt) 2015-06-10 2022-01-25 Peter Sherlock Processos para produzir um produto absorvente a partir de uma microcultura, leito animal criado a partir do processamento de uma microcultura e produto de fralda
EP3307056B1 (fr) 2015-06-10 2020-09-23 Parabel Nutrition, Inc. Appareils, procédés et systèmes pour cultiver une micro-culture impliquant un dispositif d'accouplement flottant
WO2017007830A1 (fr) * 2015-07-06 2017-01-12 Parabel Ltd. Procédés et systèmes permettant l'extraction d'un produit de polysaccharide à partir d'une micro-culture et compositions associées
MX2018001687A (es) 2015-08-10 2019-06-06 Parabel Ltd Metodos y sistemas para extraer proteina de acido oxalico reducido de especies acuaticas y composiciones de la misma.
WO2017044966A1 (fr) 2015-09-10 2017-03-16 Parabel Ltd. Procédés et systèmes de traitement d'un produit protéique à haute concentration provenant d'une microplante et compositions associées
EP3195856A1 (fr) * 2016-01-20 2017-07-26 Teh Fong Min International Co., Ltd. Extrait de caulerpa lentillifera inhibant une allergie, son procédé de préparation et ses applications
FR3112486B1 (fr) 2020-07-15 2023-05-26 Laboratoires Dermatologiques Duriage Composition cosmétique détoxifiante
FR3112488B1 (fr) 2020-07-15 2023-12-15 Algues Et Mer Utilisation d’un extrait de Codium fragile riche en arabinogalactanes sulfatés dans des compositions cosmétiques anti-âge.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
KR101571571B1 (ko) * 2007-08-24 2015-11-24 마리노메드 바이오테크놀로지 게엠베하 황화 폴리사카라이드를 포함하는 항바이러스 조성물
US7867523B2 (en) 2008-07-18 2011-01-11 Vanterpool Elaine A Pharmaceutical composition
RU2401117C1 (ru) * 2009-04-06 2010-10-10 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Средство для профилактики гриппа и острых респираторных заболеваний
EP2327411A1 (fr) * 2009-11-27 2011-06-01 Lonza Ltd. Arabinogalactane en tant qu'améliorant immunitaire
JP5666167B2 (ja) 2010-05-07 2015-02-12 日本発條株式会社 ステージヒータ及びシャフトの製造方法

Also Published As

Publication number Publication date
US9011939B2 (en) 2015-04-21
EP2675462A2 (fr) 2013-12-25
CN103476418B (zh) 2017-07-14
FR2969926A1 (fr) 2012-07-06
WO2012093234A2 (fr) 2012-07-12
US20140023675A1 (en) 2014-01-23
WO2012093234A3 (fr) 2012-09-13
BR112013017178A2 (pt) 2016-10-04
CN103476418A (zh) 2013-12-25

Similar Documents

Publication Publication Date Title
FR2969926B1 (fr) Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
BR112015002524A2 (pt) derivados de alquilpirimidina para o tratamento de infecções virais e outras doenças.
SMT201600470B (it) Inibitori del virus dell'epatite c
EA201391719A1 (ru) Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
SMT201700029B (it) Inibitori del virus dell'epatite c
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
HK1210463A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
EP2753618A4 (fr) Dérivés benzofuranes substitués par un hétérocycle et leurs procédés d'utilisation pour le traitement de maladies virales
CO6940374A2 (es) Composiciones, usos y métodos para tratamiento de trastornos y enfermedades metabólicas
BR112013020425A2 (pt) composições e métodos para o tratamento ou prevenção de infecção por vírus da hepatite b
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK2747763T3 (da) (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser
EA201500383A1 (ru) Производные 1,2,4-триазина для лечения вирусных инфекций
EP2753611A4 (fr) Composés benzofuranes substitués et leurs procédés d'utilisation pour le traitement de maladies virales
SMT201700028B (it) Composti benzofuranici per il trattamento delle infezioni da virus dell’epatite c
HK1210025A1 (en) Method and agent for the treatment and prophylaxis of diseases caused by ()rna-containing viruses ()rna
BR112014025339A8 (pt) método para tratamento ou prevenção ou redução de infecção do virus influenza e composição farmacêutica para o mesmo.
DK2961426T3 (da) Behandling af sygdomme i centralnervesystemet ved intranasal indgivelse af immunoglobulin g
BR112014003556A2 (pt) método de tratamento de vírus, e, composição farmacêutica
DK2900259T3 (da) Glycosidase-regime til behandling af infektionssygdomme
CL2015000037A1 (es) Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano.
EA201592242A1 (ru) Производные пиридона для лечения вирусных инфекций и других заболеваний
CO6801768A2 (es) Procesos para la preparación de inhibidores del virus de la hepatitis
BR112014002290A2 (pt) vírus recombinante de influenza suína e usos do mesmo

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14